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Abstract
Background:  Insect neuropeptides are distributed in stereotypic sets of neurons that commonly
constitute a small fraction of the total number of neurons. However, some neuropeptide genes are
expressed in larger numbers of neurons of diverse types suggesting that they are involved in a greater
diversity of functions. One of these widely expressed genes, snpf, encodes the precursor of short
neuropeptide F (sNPF). To unravel possible functional diversity we have mapped the distribution of
transcript of the snpf gene and its peptide products in the central nervous system (CNS) of Drosophila in
relation to other neuronal markers.
Results: There are several hundreds of neurons in the larval CNS and several thousands in the adult
Drosophila  brain expressing snpf  transcript and sNPF peptide. Most of these neurons are intrinsic
interneurons of the mushroom bodies. Additionally, sNPF is expressed in numerous small interneurons of
the CNS, olfactory receptor neurons (ORNs) of the antennae, and in a small set of possibly
neurosecretory cells innervating the corpora cardiaca and aorta. A sNPF-Gal4 line confirms most of the
expression pattern. None of the sNPF immunoreactive neurons co-express a marker for the transcription
factor DIMMED, suggesting that the majority are not neurosecretory cells or large interneurons involved
in episodic bulk transmission. Instead a portion of the sNPF producing neurons co-express markers for
classical neurotransmitters such as acetylcholine, GABA and glutamate, suggesting that sNPF is a co-
transmitter or local neuromodulator in ORNs and many interneurons. Interestingly, sNPF is coexpressed
both with presumed excitatory and inhibitory neurotransmitters. A few sNPF expressing neurons in the
brain colocalize the peptide corazonin and a pair of dorsal neurons in the first abdominal neuromere
coexpresses sNPF and insulin-like peptide 7 (ILP7).
Conclusion:  I t  i s  l i k e l y  t h a t  s N P F  h a s  m u l t i p l e  f u n c t i o n s  a s  n e u r o h o r m o n e  a s  w e l l  a s  l o c a l
neuromodulator/co-transmitter in various CNS circuits, including olfactory circuits both at the level of the
first synapse and at the mushroom body output level. Some of the sNPF immunoreactive axons terminate
in close proximity to neurosecretory cells producing ILPs and adipokinetic hormone, indicating that sNPF
also might regulate hormone production or release.
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Background
Insect neuropeptides are commonly expressed in discrete
stereotypic populations of neurons in the central nervous
system [1-7]. These populations vary in size for different
neuropeptides. Thus, some Drosophila neuropeptides such
as SIFamide and eclosion hormone are found in very
small numbers of uniform neurons [8-11], whereas others
like tachykinin-related peptides (TKRPs), proctolin, and
myoinhibitory peptides (MIPs) are expressed in large pop-
ulations of diverse neurons [7,12,13]. A closer look at the
expression of different insect neuropeptides has revealed
that some peptides are prominent in neurosecretory cells
and other endocrine cells and play roles as circulating hor-
mones (see [3,14,15]). Many peptides are found both in
endocrine systems and in interneurons and thus they are
likely to have several functions, including modulatory
actions in central circuits (reviewed in [3,16]). A few pep-
tides can additionally be seen in skeletal or visceral
motoneurons [17,18]. Finally, some Drosophila neuropep-
tides appear to be exclusively expressed in interneurons,
for example the TKRPs, SIFamide and A-type allatostatins
[8,12,19], but there are so far no clear demonstrations of
identified insect neuropeptides in sensory neurons (see
[3,16]). Taken together the available data suggest that
neuropeptides can act in diverse ways as neuromodulators
or cotransmitters in the CNS, as circulating hormones and
as neuromediators released by neurons at peripheral tar-
gets. Thus, one may ask to what extent a neuropeptide that
is widely distributed in many types of neurons is multi-
functional. Or, differently phrased, does a given peptide
expressed in a diverse set of neuronal circuits and neuron
types (including neurosecretory cells) subserve a global
unified function or a multitude of separate distributed
functions? To address this question we analyzed a Dro-
sophila peptide gene with very wide distribution.
Recently it was demonstrated that the Drosophila  gene,
snpf, that encodes the predicted peptides short neuropep-
tide F 1 – 4 (sNPF 1 – 4), is expressed by numerous neu-
rons of the Drosophila brain [20,21]. The study by Johard
et al. [21] focused on the presence of snpf in Kenyon cells
of the mushroom bodies, known to be the intrinsic com-
ponents of this brain center subserving, among other
things, higher olfactory processing and learning [22,23].
During the analysis of the mushroom body circuits it was
noted that snpf transcript and peptide products are distrib-
uted in a large population of different types of neurons
throughout the Drosophila CNS. Thus we decided to map
the distribution of sNPFs in relation to other neurotrans-
mitters, neuronal circuits and compartmental boundaries
(segments/neuromeres) of the CNS to allow analysis of
substrates for possible diversity of functional roles.
We made a detailed mapping of sNPFs, especially in
interneurons of various brain centers in larvae and adult
Drosophila. For immunocytochemical charting we used
specific antisera to two of the peptide products of the snpf
gene as well as a sequence of the precursor protein. This
was compared with in situ hybridization with a ribonucle-
otide probe to the snpf transcript. A sNPF-Gal4 line was
used for driving green fluorescent protein (GFP) and the
labeling pattern compared to sNPF immunolabeling. To
screen for colocalized neurotransmitters and to analyze
relations to identified structures we mapped sNPF expres-
sion in relation to specific neurons identified by Gal4
driven GFP. This analysis included the relation between
sNPF expression and that of the transcription factor
DIMMED (DIMM), known to be present in secretory pep-
tidergic neurons [15,24]. A fasciclin-2 (Fas2) marker was
utilized to relate neurons to axon tracts and segmental
compartments [7,25]. One of the major findings is that
snpf products are expressed in a very large number of neu-
rons of diverse types (some of which co-express markers
for various small molecule neurotransmitters) suggesting
multiple functions of these peptides. No overlap was seen
between sNPF and DIMM expression. A novel and excit-
ing finding was the presence of sNPF in a subpopulation
of the olfactory receptor neurons of the antennae and in a
pair of abdominal projection neurons co-expressing insu-
lin-like peptide 7 (ILP7).
Results
Distribution of sNPF in the larval CNS
In situ hybridization in larval CNS
A general description of the distribution of snpf transcript
in the embryonic and larval CNS has been provided ear-
lier [20]. Here we provide a more detailed localization of
transcript by in situ hybridization in the brain and ventral
cord of the third instar larva. Six larval CNS were used for
analysis of hybridization pattern.
In the larval brain and subesophageal ganglion there are
about 35 neurons in each hemisphere expressing in situ
signals, in addition to numerous Kenyon cells (see [21]).
These neurons are located dorsally and ventrally in the
protocerebrum and in the subesophageal ganglion (Fig.
1A, B). Three strongly in situ labeled neurons in each pro-
tocerebrum have larger cell bodies (Fig. 1A, B, see also 1E)
and are likely to be neurosecretory cells (see next section).
In the ventral nerve cord there are segmentally distributed
neurons both in thoracic and abdominal neuromeres
(Fig. 1C, D). In each side of the thoracic and abdominal
neuromeres there are three to four lateral cell bodies and
one dorso-median cell body (Fig. 1C, D). In abdominal
neuromeres A7 and A8 there are additional labeled cell
bodies with larger diameters (Fig. 1D). A characteristic
pair of larger cell bodies (DP) can be seen dorsally and
medially in A1 (Fig. 1C, D). The segmental distribution
and numbers of in situ labeled neurons match the pattern
displayed by sNPF immunolabeling (see Fig. 1E).BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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Immunocytochemistry in larval CNS
The immunolabeling with antiserum to the sNPF precur-
sor derived peptide (sNPFp) was found most consistent
and reliable. This antiserum recognizes a peptide
sequence not shared with other known neuropeptides
and thus presumably only labels neurons producing the
sNPF precursor. Also the antiserum to the RLRWamide
sequence is likely to only bind to sequences present on the
sNPF precursor (the predicted sNPF-3 and 4) [21]. On the
other hand the antiserum to sNPF-14–11 (with a RLRFa-
mide C-terminus) is likely to cross react also with neurons
expressing peptides with RFamide in the C-terminus such
as: long NPF (dNPF), extended FMRFamides (dFMRFa),
myosuppressin (DMS) and sulfakinins (DSKs). Thus after
confirming that the antisera to sNPFp and RLRWamide
labeled what appears to be the same neuron populations
and that the antiserum to RLRFamide labels these neurons
plus additional ones [21], we decided to use the sNPFp
antiserum throughout the present investigation. This
antiserum was characterized for specificity by Johard et al.
[21]. It can be mentioned that in the investigation by Lee
et al. [20] an antiserum to a full-length sNPF-2 was used.
That antiserum is likely to cross react with other RFamide-
containing neuropeptides, and indeed these authors
describe neurons additional to those shown here.
The number of neuronal cell bodies given below refers to
both hemispheres (unless specified). One characteristic of
the sNPFp immunolabeling is a variability in labeling
intensity, especially in smaller neurons. Furthermore the
labeling of neuronal processes is punctate and thus it is
hard to resolve the axonal projections and therefore indi-
vidual neurons could not be fully reconstructed morpho-
logically. We examined sNPFp immunolabeling patterns
in at least 10 specimens of each stage. It can be noted that
the sNPFp immunlabeling pattern of cell bodies, closely
resembles that seen after snpf in situ hybridization.
There are up to 600 Kenyon cells per larval hemisphere
[26]. As shown earlier [21] most of these appear to be
sNPFp-immunoreactive (sNPFp-IR). In addition there are
about 190 – 200 sNPFp-IR neuronal cell bodies in the lar-
val CNS (as summarized in Fig. 1E). Of these about 70 are
in the brain, including the subesophageal ganglion, and a
minimum of 120 consistently labeled neurons in the tho-
racic and abdominal neuromeres (Fig. 1E, 2, 3). There is
some variability in the number of small neurons labeled
with the sNPFp antiserum, both in the brain and the ven-
tral ganglia. Thus, in well-labeled specimens we can
observe additional small cell bodies, especially in the
abdominal ganglia.
The sNPFp-IR neuronal cell bodies in the larval brain and
subesophageal ganglion are distributed in several bilateral
clusters: around 20 – 26 cell bodies are located in the
subesophageal ganglion and the remaining ones in differ-
ent parts of the protocerebrum (Fig. 1E, 2A–D). Three
pairs of intensely immunolabeled cells dorsally in the
protocerebrum are likely to be neurosecretory cells
(LNCs) of the pars lateralis (Fig. 1E, 2D). These LNCs have
axons terminating in the ring gland (corpora cardiaca por-
tion) and in the anterior aorta. We will describe these neu-
rosecretory cells and their neurohemal release sites in
more detail below.
In the larval brain branching sNPFp-IR processes were
seen in neuropils of the protocerebrum, deutocerebrum
and subesophageal ganglion (Fig. 2A–D). The most dense
immunolabeling is in the lobes of the mushroom bodies
(Fig. 2A, C, D). Further sNPFp immunolabeling of proc-
esses is seen in the larval optic center (Fig. 2A) and in non-
glomerular neuropils surrounding mushroom body lobes
and in pars intercerebralis and lateralis (Fig. 2A–D). A
movie with a rotating view of the brain is shown in Addi-
tional File 1.
Cell bodies of snpf/sNPF expressing neurons in the larval CNS Figure 1 (see previous page)
Cell bodies of snpf/sNPF expressing neurons in the larval CNS.In situ hybridization reveals snpf transcript in A-D and 
immunocytochemistry displays cell bodies in E. A. In situ signal in neurons of the protocerebrum (Pro) of the brain and 
subesophageal ganglion (SEG). DLN, dorsolateral neurons (including possible neurosecretory cells). B. Higher magnification of 
the right brain hemisphere in another specimen reveals numerous Kenyon cells (KC) of the mushroom body and three of the 
strongly labeled cell bodies dorsally (asterisk) that may represent neurosecretory cells. C and D. In the ventral nerve cord 
segmentally arranged cell bodies display in situ signal. Eight abdominal neuromeres are indicated (A1 – A8). The boxed areas 
are shown in higher magnification in C', C" and D': in C" and D' lateral cell body clusters are shown with 4 – 5 neurons in each 
hemineuromere and in C' the two dorsal cell bodies (DP) of A1 are visible. E. Tracing of cell bodies labeled with antiserum to 
sNPF precursor-derived peptide (sNPFp). In this tracing only strongly labeled cell bodies are depicted and the Kenyon cells 
were ommitted. Additional small cell bodies with variable labeling intensity can be seen in brain and ventral nerve cord. Red cell 
bodies are dorsal, black ones ventral or lateral and yellow ones dorsal and with larger diameters (yellow cellbodies in the brain 
probably correspond to the ones indicated with asterisk in B). Two groups of cell bodies are indicated, DLN and DP. T1 – T3, 
thoracic neuromeres, other abbreviations as in A – D.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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The general distribution of sNPFp-IR neuronal cell bodies
in thoracic and abdominal neuromeres is shown in Fig. 1E
and 3. These cell bodies are of three general size classes:
small, intermediate and larger. There are only six larger
and 12 intermediate sized cell bodies, the remaining ones
are small. As mentioned, the variable labeling is only seen
for the small cell bodies.
The cell bodies in thoracic and abdominal neuromeres are
located dorsally, ventrally and laterally; the former two
either along the midline or more laterally (Fig. 1E, 3). By
double labeling with antisera to sNPFp and fasciclin 2
(fas2), that labels major axonal tracts [7,25], we could
relate the cell bodies to the different neuromeres of the
ventral ganglia (Fig. 3). From this we could reveal that in
each of the three thoracic neuromeres there is only one
pair of neurons with intermediate sized cell bodies. How-
ever, there are up to four additional pairs of neurons with
small lateral cell bodies in each of the thoracic neu-
romeres. Also medially there are at least two small ventral
neurons per neuromere.
The abdominal neuromeres display sNPFp immunoreac-
tivity in many small neurons laterally and ventrally (Fig.
1E, 2E, F). In A1 – 4 there are at least 4 – 6 lateral small
neurons and 2 – 4 median/ventral ones per neuromere
(Fig. 1E, 3). A5 – A8 have 2 – 6 lateral and 2 median small
cell bodies (Fig. 1E, 3). In some specimens these posterior
neuromeres appear to lack lateral small neurons (or dis-
play weak label). Finally, in each of A6 – 8 there is a pair
of intermediate size cell bodies laterally. Two groups of
large sized abdominal neurons stand out as individually
identifiable: one pair dorsally in A1 (DP) and two pairs
posteriorly in A8 (see Fig. 1E, 2E, F, 3B, C).
Two pairs of major bundles of sNPR-IR axons were found
in the ventral ganglia. These are located ventrally and
medially in the ganglia, and are associated with the dorso-
median (DM) and ventro-median (VM) tracts (Fig. 2E, 3).
The axons in the VM tracts form numerous varicosities
and dorso-ventral branches along their course (see movie
in Additional File 2). Additionally two pairs of thin lateral
tracts near the CI tracts contain sNPFp-IR axons (Fig.
3C2). sNPFp-IR punctates are seen in several neuropil
areas both dorsally and ventrally in the thoracic and
abdominal neuromeres (Fig. 2E, F). The delineated
neuropil posteriorly in A8/9 (designated terminal plexus
[7]) is densely supplied with sNPFp-IR punctates (Fig. 2F).
We detected no clear cases of sNPFp-IR axons in commis-
sural tracts of thoracic and abdominal neuromeres, but
immunoreactive punctae could be seen in transverse
bands in each neuromere (Fig. 2E, F). None of the neu-
rons in the thoracic and abdominal neuromeres seem to
send axons through peripheral nerve roots, suggesting
that they are all interneurons. A view of sNPF-IR neurons
in the ventral nerve cord is shown in the movie in Addi-
tional File 2.
Expression of sNPF-Gal4 in the larval CNS
To our knowledge this is the first report on the expression
pattern of the sNPF-Gal4 (NP6301). Using this sNPF-Gal4
in third instar larvae we found a GFP expression pattern
similar to the distribution of sNPFp-IR neurons (Fig. 4).
Double labeling with sNPFp antiserum indeed indicated
that most if not all neurons in the thoracic and abdominal
ganglia expressed both markers (Fig. 4C, D). A set of seg-
mental dorsal median cell bodies in abdominal neu-
romeres display sNPF-Gal4, but not sNPF-IR material
(Fig. 4C). In the brain the match was not complete, prob-
ably due to low expression levels of GFP in some neurons
(not shown). There were also some neurons where GFP
was seen, but not immunolabeling; probably caused by
the variable immunolabeling seen in some of the smaller
neurons.
In the ventral nerve cord we could detect the typical pat-
tern of sNPF expressing cell bodies, but now also the
details of their axonal projections and arborizations (Fig.
4A – C). It is obvious that sNPF expressing neurons supply
processes to several neuropil areas in the thoracic and
abdominal ganglia, as already indicated with less clarity
by immunolabeling. We detected no efferent or afferent
axons in the ventral nerve cord suggesting that all sNPF
expressing neurons in this region are interneurons.
Immunolabeling with antiserum to sNPFp in the larval CNS Figure 2 (see previous page)
Immunolabeling with antiserum to sNPFp in the larval CNS. Horizontal views, anterior is to the top in all 
images. A – C. Three different levels of the left brain hemisphere displaying immunolabeled neuronal cell bodies and proc-
esses in neuropils (e. g. at arrows). LOC, larval optic center; βL, β-lobe and P, peduncle of mushroom body; SEG, subesopha-
geal ganglion. D. A threshold-based 3D reconstruction of the brain, subesophageal ganglion (SEG) and first part of thoracic 
ganglia (TG). Note strong labeling of mushroom body lobes and peduncle (αL, βL, P) and axonal projections to the anterior 
aorta (Ao) and corpora cardiaca (CC) of the ring gland. The mushroom body calyx (Ca) is less intensely labeled. A bilateral 
cluster of cell bodies (at arrows) contain the lateral neurosecretory cells supplying axons to the ring gland. E and F. Confocal 
sections of immunolababeling in the ventral nerve cord with thoracic (T1 – T3) and abdominal (A1 – A8/9) neuromeres. Punc-
tate sNPFp immunosignals are seen in neuropils laterally (ar) and medially, as well as in longitudinal tracts (e. g. at arrow in E) 
and segmental commissures tracts (e. g. at arrow in F). Immunolabeling is also seen in the terminal plexus in A8 and A9.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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In the larval brain the most prominent sNPF-Gal4 expres-
sion was seen in Kenyon cells of the mushroom bodies
(Fig. 4E). The entire neuronal morphology of these
Kenyon cells was revealed and it was clear that some neu-
rons in the core of the calyx and lobes do not express GFP
(Fig. 4F, G), similar to the sNPFp antiserum labeling [21].
This Gal4 line also enabled us to see the neurosecretory
cells supplying axons to the ring gland (corpora cardiaca),
as will be described below. Sets of Gal4 expressing axons
were seen in the nerves entering the larval olfactory cent-
ers in the brain. These may be subsets of axons from ORNs
of the dorsal organs as also suggested from in situ labeling
in the late embryo [20].
Supply of sNPF expressing axons to the ring gland and 
aorta
The neurohemal organ of the larval brain, the ring gland,
is situated around the anterior aorta (Fig. 5A–C). A variety
of brain neurosecretory cells are known to innervate dif-
ferent parts of the ring gland and aorta [27]. We detected
varicose axons displaying strong sNPF immunolabel that
supply the ring gland and aorta (Fig. 5A–D). Interestingly,
it appears that the sNPF-IR axons entering the ring gland
extend only into the glandular lobes where the adipoki-
netic hormone (AKH) producing cells reside [27] (Fig. 5C
– E). As seen in Fig. 5D–E it appears that the sNPF-IR
axons terminate onto the AKH producing cells visualized
with the c929-Gal4 line that displays DIMM expression,
characteristic of neurosecretory cells {Park, 2008 #92}.
Another supply of sNPF-IR axons terminate on the wall of
the anterior aorta (Fig. 4A–C). It was not possible to
clearly identify the cell bodies of the neurons (neurosecre-
tory cells) that supply the axons to the ring gland and
aorta by ordinary immunolabeling. However, using the
sNPF-Gal4 to drive GFP we could show axonal projections
to the ring gland and aorta from a set of three LNCs in
each hemisphere (Fig. 6A, B). We also used the sNPF-Gal4
driven GFP for double labeling with antiserum to cora-
zonin since this peptide is known to be expressed in three
pairs of LNCs in the larva [27-30]. We found that the three
pairs of LNCs with projections to the ring gland coexpress
sNPF and corazonin (Fig. 6C). Curiously the sNPF-Gal4
expression was also seen in the AKH producing cells of the
ring gland, but this is likely to be ectopic expression since
we could not detect sNPFp immunoreactivity or snpf in
situ signal in these glandular cells.
When analyzing the sNPF distribution in the LNCs and
ring gland it was also apparent that sNPFp immunoreac-
tive varicose axons terminate close to the dendrites of the
insulin-like peptide (ILP) expressing (using a dilp2- and
c929-Gal4) median neurosecretory cells (Fig 5E, F). This
was also seen in a recent paper by Lee et al. [31]. The
source of some of these sNPF expressing axons will be
described later.
sNPF in adult brain
In situ hybridization
In situ hybridization with snpf antisense probe was per-
formed on wholemounts of adult brains. Additionally to
the numerous Kenyon cells (up to 2500 in each mush-
room body [26]), a total of at least 280 neuronal cell bod-
ies were seen labeled with the probe in the brain,
including the subesophageal ganglion (Fig. 7). Again,
three main size classes of neuronal cell bodies were
detected and the smallest neurons were the ones display-
ing variability in intensity of staining and thus the
number of clearly detectable cell bodies varied.
In the subesophageal ganglion there is a total of at least 28
neurons distributed in three bilateral groups: one pair of
clusters (S1) close to the esophageal foramen, another
pair (S2) ventro-laterally in the ganglion, and a third pair
(S3) dorso-laterally (Fig. 7A, B). These neurons have cell
bodies of small or intermediate size.
At the base of each optic lobe there are clusters of about
50 small cell bodies (OL2), distributed both anteriorly
Relation between sNPFp immunolabeled structures and fasciclin2 (Fas2)-immunolabeled tracts/boundaries in the larval ventral  cord Figure 3 (see previous page)
Relation between sNPFp immunolabeled structures and fasciclin2 (Fas2)-immunolabeled tracts/boundaries in 
the larval ventral cord. These are voltex reconstructions from confocal image stacks. A1 – A4. Specimen double labeled 
with sNPFp (green) and anti-Fas2 (magenta) reveals segmental organization of cell bodies and relation of sNPFp-IR axon tracts 
to Fas2 tracts. In A1–A3 maximum projections are shown and in A4 a voltex reconstruction (see methods). B1 – B4. A cross 
section through first abdominal segment (neuromere A1) showing relations between sNPF labeled structures and Fas2 tracts. 
The dorsal median cell bodies of A1 are visible (DP) as well as axons in the major ventral median tracts (VM and DM; see C2) 
and along the C1 tract (arrow head). C1. Schematic presentation of sNPFp labeled neurons (grey and green) and Fas2 tracts 
(magenta) revealing segmental localization of cell bodies, dorsal view. C2. Transverse view of A1 showing sNPFp-IR cell bodies 
(grey and green) and axons (green) in relation to Fas2 labeled tracts (magenta). Grey: small cells with variable and weaker stain-
ing intensity, Green: larger cells with consistent and strong staining intensity. The longitudinal tracts are designated DL (dorso-
lateral), DM (dorso-medial), VM (ventro-medial), CI (centro-intermediate), CL (centro-lateral) and VL (ventro-lateral) and 
transverse tracts 1 – 4. Note that cell bodies located dorsally, laterally and ventrally. Scale bars: 50 μm in A1–A4, 30 μm in B1–
B4.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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Expression of sNPF-Gal4 driven GFP in the larval CNS Figure 4
Expression of sNPF-Gal4 driven GFP in the larval CNS. The NP6301 Gal4 line appears to match the sNPF 
immunolabeling as seen in these dorsal views of the ventral nerve cord (A-D and brain (E-G). Anterior is up in 
the images. A. sNPF-Gal4 expression in third thoracic and first three abdominal neuromeres. Segmentally arranged lateral cell 
bodies (LCb) and the dorsal pair (DP) in A1. B. Detail of the DP neurons and longitudinal axonal tracts (arrows). C1 and C2. 
Double labeling with sNPF-Gal4-GFP and anti-sNPFp in abdominal neuromeres. Note that with a few exceptions the two 
markers colocalize. A set of median segmental neurons (ML) and some posterior neurons (arrow) express only sNPF-gal4. 
D1-3. Expression of immunolabeling and Gal4 in processes of the terminal plexus in A8/9 (arrows). E-G. In the larval brain the 
intrinsic neurons of the mushroom bodies express sNPF-Gal4. GFP can thus be seen in α,β and γ-lobes, the peduncle (P) and 
calyx (Ca). Note that the core of the lobes is devoid of GFP (arrows). In G the cell bodies of the Kenyon cells are depicted.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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Figure 5 (see legend on next page)BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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Distribution of sNPF precursor immunoreactivity (sNPFp-IR) in relation to the ring gland and anterior aorta of the larva (ante- rior is up) Figure 5 (see previous page)
Distribution of sNPF precursor immunoreactivity (sNPFp-IR) in relation to the ring gland and anterior aorta 
of the larva (anterior is up).A. sNPFp-IR (red) in brain and the corpora cardiaca (CC) portion of the ring gland and aorta 
(Ao). Immunolabeling is also seen in peduncle (P) and β and γ-lobes of the mushroom bodies. B and C. Dorsal (B) and ventral 
(C) aspects of retrocerebral complex in superimposed Nomarsky optics and immunofluorescence. In B the sNPFp-IR proc-
esses on the aorta are seen and in C the axons in the CC part of the ring gland. D. Double labeling with c929-Gal4-driven GFP 
(to display DIMM expression) and anti-sNPFp (magenta) shown from stack of confocal images. The c929 displays AKH-produc-
ing cells in the CC and median neurosecretory cells (MNC) in the pars intercerebralis some of which produce insulin-like pep-
tides. Note sNPFp-IR axons invading the CC (asterisk) and a region adjacent ot the MNCs (arrow). The mushroom body calyx 
(Ca), peduncle (P) and lobes (α and γ) are indicated. E1 – E4. Confocal sections with details of sNPFp-IR fibers invading the 
corpora cardiaca portion of the ring gland. In E1 sNPFp processes are shown and in E2 c929-Gal4-driven GFP in neurosecre-
tory cells in the CC and pars intercerebralis (MNC). Note dendritic branches of the neurosecretory cells (arrow). E3 shows 
the merged image with superposition of sNPFp-IR processes with endocrine cells in corpora cardiaca (CC and asterisk) and 
branches at arrow. E4 An enlarged detail of the dendrites of the MNCs in E3 (left hemisphere) with impinging sNPF-IR termi-
nations. F Using a Dilp2-Gal4 to drive GFP it can be seen that the sNPF terminations superimpose on processes of the Dilp2-
expressing neurons.
Neurosecretory cells that express sNPF and corazonin Figure 6
Neurosecretory cells that express sNPF and corazonin.A. The source of the sNPF-Gal4 expressing axon terminations 
in the ring gland can be traced to a set of three neurons (NC) dorsal to the mushroom body calyces (Ca). B. The axons from 
the three neurosecretory cells (arrows) can be followed to the corpora cardiaca (CC). In the CC there appears to be ectopic 
expression of sNPF-Gal4 in the intrinsic AKH producing cells. KC, Kenyon cells of the mushroom body. C1-3. The three 
sNPF-expressing neurosecretory cells also display corazonin-immunoreactivity (magenta).BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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and posteriorly (Fig. 7A). In the dorsal protocerebrum
there are several clusters of labeled cell bodies. Most of
these are located posteriorly; only four anterior cell bodies
were reproducibly labeled (Fig. 7A). The more prominent
neuron groups are two dorsal clusters, each with 8 – 10
intermediate sized cell bodies, a set of about 24 small neu-
rons dorso-medially, two pairs of large cell bodies later-
ally and medially and two sets of four large intensely
labeled cell bodies, likely to be neurosecretory (LNCs)
(Fig. 7A–D). Also some cell bodies in dorso-lateral pro-
tocerebrum display strong in situ signals (in the DLN clus-
ter of Fig. 7A). The designations of the neuron groups in
Fig. 7A are used in the next section when we describe
sNPF-IR neurons.
Immunolabeling
Wholemount immunocytochemistry was not optimal for
the adult brain. Thus, most data presented here were
derived from cryostat sections. Therefore cell body counts
were less reliable and were only tried for some neuron
groups. In general sNPFp-IR cell bodies were found in the
same groups as with in situ hybridization (compare Fig.
7A and 8). Also for the adult brain the smaller cell bodies
displayed more variable immunolabeling.
A very large number of neuronal cell bodies were immu-
nolabeled (anti-sNPFp) in the adult brain. As described
previously [21] most of the 2500 Kenyon cells of each of
the mushroom bodies were weakly labeled. Approxi-
mately the same numbers of cell bodies were seen in
proto-, deuto- and tritocerebrum and in the subesopha-
geal ganglion as seen after in situ hybridization. Most of
the cell bodies were small, but some larger and intermedi-
ate sized ones were also detected. Two clusters of larger
cell bodies were seen posteriorly in the protocerebrum
(four in each hemisphere) and are likely to be neurosecre-
tory cells (Fig. 8A, B; yellow ones in Fig 7A). The promi-
nent dorsal protocerebral cell groups, DLN1, were
intensely immunolabeled (Fig. 8A, C). These DLN1s may
include small LNCs known to express corazonin (see Fig.
6C) [28,29].
Most of the neuropil regions of the brain were supplied by
varicose sNPFp-IR processes. In the protocerebrum punc-
tate immunolabeling was seen in two layers of the fan-
shaped body of the central complex (Fig. 8C, E), in the
lobes of the mushroom bodies (Fig. 8D), in the basal por-
tion of the medulla and in the lobula of the optic lobe (see
later section; Fig. 10) and diffusely in non-glomerular
neuropil throughout the protocerebrum (Fig. 8A–D). No
labeling was detected in the ellipsoid body or the pro-
tocerebral bridge of the central complex (not shown).
In the deutocerebrum punctate immunolabeling was seen
in a subset of glomeruli of the antennal lobes (Fig. 8D).
This immunolabeling is located in the olfactory receptor
neurons (ORNs) of the antenna and their axons and will
be described in more detail in conjunction with an acetyl-
choline marker (Cha-Gal4) in a later section (referring to
Fig. 13A–C). Some cell bodies were found adjacent to the
antennal lobe, but we could not resolve any processes
entering the glomeruli suggesting that none of the local
and projection interneurons of the antennal lobe express
sNPF. Tritocerebral neuropil contains a dense supply of
sNPFp-IR processes (Fig. 8D).
Extensive immunolabeling was seen in processes in
subesophageal neuropil regions and in the three different
clusters of cell bodies indicated by in situ hybridization
(Fig 8I). However, there was no evidence for afferent
axons of sensory neurons (such as gustatory receptors).
Expression of sNPF-Gal4 in the adult brain
In the adult brain the sNPF-Gal4 expression was most
obvious in the mushroom bodies, but also in most other
neurons indicated from immunocytochemistry and in
situ hybridization (Fig. 9). Most of the neuronal cell
groups shown in Fig. 7 could be identified (examples in
Fig. 9). Gal4 expression was seen in detail in neuronal
In situ hybridization with nucleotide probe to snpf in the adult brain Figure 7 (see previous page)
In situ hybridization with nucleotide probe to snpf in the adult brain. The brain and subesophageal ganglion 
(SEG) is shown in frontal views (dorsal is up). A. Schematic tracing of snpf expressing cell bodies in brain. Red cell bodies 
are posterior, black ones anterior and yellow are posterior and large intensely labeled ones. The cell body groups in the pro-
tocerebrum have been designated as follows: DLN1 and 2, dorso-lateral neurons; PI, pars intercerebralis neurons; DMN, dor-
sal median neurons, M1 – 4, median neurons. OL1 and 2, optic lobe neurons; NC, possible neurosecretory cells; In 
subesophageal ganglion: S1 – 3, subesophageal neurons. These designations are used in the following figures for adult neurons. 
Note that the mushroom body Kenyon cells and numerous small cell bodies distal to the medulla are not shown here. B. 
Micrograph of posterior portion of the brain with in situ signal in Kenyon cells (KC), large, possibly neurosecretory cells, and 
cell bodies in the subesophageal ganglion (SEG). The framed area is shown in D. Some of the cell bodies from A are indicated. 
C. Detail of cluster of dorsal lateral neurons (DLN1) posterior to the Kenyon cell group (left hemisphere). DMN, small median 
neurons. D. Dorsal brain (right hemisphere) with Kenyon cells (KC), a putative neurosecretory cell (NC), clusters of small 
cells (DMN and M3) and a pair of median cells (M1).BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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processes in the mushroom body calyx and lobes (Fig. 8H,
9A, B), Kenyon cells (Fig. 9C, D), the fan-shaped body of
the central complex (Fig. 8F, 9F), and in neuropils of the
subesophageal ganglion (Fig. 9A). The expression in
antennal lobe glomeruli was weaker (Fig. 9A).
Double labeling with Gal4-GFP expression and anti
sNPFp was performed to document colocalized markers
(examples in Fig. 8E-H, K). In wholemounts only more
superficially localized cell bodies and neuropils can be
readily visualized with the antiserum; thus we do not have
a complete map. However, the match between markers is
fairly good in that sNPF-IR material was rarely seen with-
out GFP; conversely there was likely ectopic expression of
sNPF-Gal4 in some neurons (including axons of R7 and 8
from the retina). In summary, the Gal4 expression is not
likely to reflect the sNPF expression faithfully, but is good
enough to give an overall view of the diversity of sNPF
neurons. Also, in neurons that can be confirmed by sNPFp
antiserum the expression is very useful for revealing neu-
ron morphologies since the immunolabeling is too punc-
tate for that.
Expression of sNPF-Gal4 and immunolabeling in the optic 
lobe
Except for the sNPF-Gal4 expression in the R7/8 photore-
ceptors there is a good match with sNPFp immunolabe-
ling in the optic lobe of the fly. We found sNPFp
immunoreactive neurons in the medulla and lobula, but
not lamina and lobula plate (Fig. 10A, B). In the medulla
there are sNPFp-IR cell bodies scattered distal to the
neuropil and two dense layers of varicose processes in the
basal neuropil (Fig. 10B). The Gal4 expression is similar
with respect to cell bodies and the basal layers (Fig. 10C).
In the lobula sNPF-Gal4 expression was seen in a set of
columnar neurons with cell bodies at the ventral base of
the neuropil and a termination area in the lateral pro-
tocerebrum (Fig. 10D, E). Especially in the distal lobula
the expression is strong. The sNPFp antiserum labels a
similar pattern in the lobula (Fig. 10F, G) although the
resolution of processes is far better with the Gal4 driven
GFP. We used a Cha-Gal4 driver to display optic lobe neu-
rons likely to express choline acetyltransferase (Cha) and
thus be cholinergic (Fig. 10A, F, H). Most of the Cha-
expressing neurons do not colocalize sNPFp immunola-
bel but there is Cha-Gal4 expression in a set of columnar
neurons similar to the sNPF-expressing ones (compare
Fig. 10E and 10F). Both sNPF and Cha markers reveal the
dense termination site in the lateral protocerebrum and
cell bodies in a similar position. It appears as if a small
subset of the Cha-expressing neurons colocalize sNPF
(Fig. 10H).
Expression of DIMM and sNPF
The transcription factor DIMMED (DIMM) is known to
specify a functional phenotype in a large subset of pepti-
dergic neurons [15,24]. These DIMM-expressing neurons,
identified by the c929-Gal4 line, are larger secretory cells
and rarely small peptidergic interneurons [32]. We used
the c929-gal4 to drive GFP for a comparison with sNPFp-
immunolabeling in third instar larvae. As shown in Fig.
11, we detected no colocalization of markers in any of the
neuronal cell bodies of the brain (Fig. 10A, B) or ventral
ganglia (Fig. 10C–E). It cannot be excluded that some
brain neurons displayed too weak GFP expression to be
detected here.
Many neurons expressing sNPF may colocalize other 
neurotransmitters
Since a large number of smaller neurons express sNPF in
Drosophila we found it likely that some would colocalize
other neuroactive compounds, such as classical neuro-
transmitters, monoamines of even other neuropeptides.
We thus used several different Gal4 lines to drive GFP to
Distribution of sNPF in the adult brain Figure 8 (see previous page)
Distribution of sNPF in the adult brain. A – D. Immunolabeling with antiserum to sNPFp in wholemounts of 
brain. A. A posterior confocal image with neuronal cell bodies (DLN1, OL1) and two of the four neurosecretory cells (NC). 
Punctate labeling is seen in superior median protocerebrum (SMP) and in central body (CB; only posterior portion seen here). 
B. More posterior view of another brain with neurosecretory cells (NC) from which axons (arrows) can be seen projecting 
towards the nerves connecting to the corpora cardiaca. Neuropil labeling is seen in ventrolateral protocerebrum (VLP) and 
posterior central body (CB). C. More anterior optical section with labeling in central body (CB), especially the lower layer 
(arrow). Other abreviations as in A. D. Image at the level of the mushroom body lobes (α, β and γ) and heel (h). Labeling is 
seen in some glomeruli of the antennal lobes (AL) and in the tritocerebrum (Tri). Two cell bodies are labeled in the pars inter-
cerebralis (PI). E. Immunolabeling in the upper (U) and lower (L) layers of the central body (fan-shaped body) and the nodules 
(arrow). F. Expression of sNPF-Gal4-driven GFP in central body for comparison. Note that E and F are from different speci-
mens. G and H. Expression of sNPFp immunolabeling (G) and sNPF-Gal4 (H) in the mushroom body lobes (a double labeled 
specimen) and some cell bodies (arrows). Note the identical expression of markers. I. Cell bodies (S2 and S3) in subesophageal 
ganglion expressing sNPR immunolabeling. K1 – 3. A double labeled specimen showing close match between immunolabeling 
and sNPF-Gal4 expression in four large protocerebral cell bodies close to the calyx of the mushroom bodies (green patch in 
upper right corner).BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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display neurons likely to produce dopamine (th; tyrosine
hydroxylase), octopamine/tyramine (tdc; tyrosine decar-
boxylase) acetylcholine (Cha; choline acetyltransferase),
glutamate (OK371; vesicular glutamate transporter;
vGluT), GABA (Gad1; glutamic acid decarboxylase) and
NPF (dNPF; long NPF). We also combined sNPF-Gal4
driven GFP with antisera to corazonin and ILP7.
Cholinergic neurons
Cha-Gal4 expression, diagnostic of acetylcholine, is
known to be abundant in numerous neurons of the Dro-
sophila CNS [33,34]. Thus it is not surprising that Cha-
Gal4 expression is seen in many of the sNPF-expressing
neurons. In the larval CNS we detected colocalization of
Cha-Gal4 and sNPF in subsets of neurons in the DLN clus-
ter of the protocerebrum (Fig. 12A) and in single neurons
scattered dorsally in the brain (Fig. 12B). In the ventral
nerve cord of larvae some of the intermediate sized cell
bodies coexpressed Cha-Gal4 and sNPF: the dorso-
median pair (DP) in A1 (Fig. 12C) and some of the lateral
neurons in A7 and A8 (Fig. 12C).
In the adult fly we found that a set of the sNPFp immuno-
reactive cell bodies of ORNs in the antennae (Fig. 13B)
and maxillary palps (not shown) and their terminations
in the antennal glomeruli coexpress Cha-Gal4 (Fig. 13A).
Whereas all antennal glomeruli display Cha-expressing
processes, only a smaller set expresses sNPF immunolabel
(Fig. 13A). We also used the Or83b-Gal4 to drive GFP in
most of the ORNs of the antennae [35] for labeling with
sNPFp antiserum and revealed a similar colocalization
pattern (not shown). Antennal lobe projection interneu-
rons express Cha, but not sNPF (Fig. 13A). Several
interneurons in the proto- and deutocerebrum as well as
the subesophageal ganglion also coexpress the two mark-
ers (Fig. 13C–F). Most of these interneurons could not be
individually identified. It appears as if there is no colocal-
ization of markers for Cha and sNPF in neuronal processes
in the central complex; the two markers were seen in dif-
ferent layers of these neuropils (Fig. 13G, H). We also
found no colocalization in other glomerular neuropils
including mushroom bodies. Probably colocalized mark-
ers are mostly confined to neuronal processes in non-
glomerular neuropils (and in ORN processes in antennal
glomeruli).
GABAergic neurons
Putative GABAergic neurons were revealed by Gad1-Gal4
expression. No colocalization of sNPFp and Gad1-Gal4
expression was detected in neuronal cell bodies of the lar-
val CNS (Fig. 14). Substantial superposition of labeled
processes was, however, detected (Fig. 14D). In the adult
brain few neurons were found to colocalize Gad1 and
sNPF markers, in the DMN and DLN2 clusters (Fig. 14F,
G; compare Fig. 7A for location).
Glutamatergic neurons
We revealed putative glutamatergic neurons in the larval
CNS with the OK371-Gal4 driver, known to reveal vGluT
distribution [36]. Some neurons in DLN cluster and oth-
ers near the mushroom body calyx of the larval protocer-
ebrum colocalize OK371-Gal4 and sNPF expression (Fig.
15A, B). No colocalization was seen in larval ventral nerve
cord, although superimposed neuronal processes were
detected in lateral neuropils (Fig. 15E-C).
Dopaminergic neurons
Tyrosine hydroxylase (th-Gal4) expression correlates well
with dopamine producing neurons [37,38]. We could not
detect any colocalization of th-Gal4 and sNPF expression
in neuronal cell bodies of the larval or adult CNS (Fig.
15F; see also [21]). However the th-expressing neurons of
the abdominal ganglia cluster with sNPF-IR neurons later-
ally in the neuromeres (Fig. 15F). No colocalization was
seen with tyrosine decarboxylase-driven GFP in the larval
CNS (not shown; but see [21]).
Distribution of sNPF-Gal4 driven GFP expression in adult brain Figure 9 (see previous page)
Distribution of sNPF-Gal4 driven GFP expression in adult brain. The Gal4 line NP6301 drives GFP in neurons 
that largely correspond to the sNPFp-IR neurons in the adult brain.A. Overview of brain in confocal section at level 
of mushroom body lobes. Strong expression is seen in axons in the α, β and γ-lobes and heel (h) of the mushroom body, and 
in processes in neuropil of the subesophageal ganglion (SEG). In glomeruli of the antennal lobe (AL) labeling is weaker at this 
level. Several groups of neuronal cell bodies are seen (e. g. PI and DLN2). A neuropil at the base of the lobula (arrow) is 
strongly expressing sNPF-Gal4 (see Fig. 10 for details). B. Detail of mushroom body lobes. The α, β and γ-lobes and heel (h) 
contain fibers expressing sNPF, whereas the α' (not seen) and β' do not. The arrow indicates a set of small median neurons 
(DMN in E). C. Overview of dorsal brain at level of mushroom body calyces (Ca). Kenyon cells (KC) and their processes 
express sNPF. A pair of large median neurons (MN1, see Fig. 7A) can be seen. D. Detail of mushroom body calyces (Ca) with 
numerous Kenyon cells (KC) and sets of DNL1 neurons. E. A set of dorsal median neuron cell bodies (DMN) located between 
the tips of the α-lobes. F. Cell bodies of the median neurons in the pars intercerebralis (PI) and their axons (arrow), dorsal to 
the central body (CB). Two layers of sNPF-expresing processes are seen in the central body. Strong sNPF expression is seen in 
axons of the cross-sectioned mushroom body peduncles (P).BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
Page 18 of 35
(page number not for citation purposes)
Figure 10 (see legend on next page)BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
Page 19 of 35
(page number not for citation purposes)
Peptidergic neurons
We used several markers for peptides to reveal relations to
sNPF-expressing neurons (Fig. 16). First, we were inter-
ested to reveal whether the sNPF antiserum cross reacted
with dNPF (long NPF). Analyzing distribution of GFP
driven by a dNPF-Gal4, known to be specific for dNPF
expression[39], with antiserum to sNPFp, we found that
only two neurons in the adult brain colocalize markers
(Fig. 16A). These are in the DLN1 cluster. There is exten-
sive superposition of sNPF and dNPF-labeled processes in
the dorsal protocerebrum. In the larval CNS there is no
colocalization at all (see [21]).
The Mai179 enhancer trap line drives GFP in subsets of
brain neurosecretory cells and other, possibly peptidergic,
neurons [27]. We found that a small set of Mai179
expressing neurons (PI) in the adult pars intercerebralis
coexpress sNPF (Fig. 16C, D). These PI neurons appear to
be interneurons rather than neurosecretory cells.
Corazonin is expressed in a small set of neurons and neu-
rosecretory cells in the Drosophila CNS [29,30]. We have
shown already that three pairs of brain neurosecretory
cells colocalize sNPF and corazonin (Fig. 16C). In the ven-
tral nerve cord there is a set of 14 segmentally distributed
corazonin-immunoreactive neurons. These do not colo-
calize sNPF (Fig. 16E).
It has been shown that insulin-like peptide 7 (ILP7), with
resemblance to mammalian relaxin, is distributed in
interneurons and efferent neurons of the Drosophila
abdominal ganglia [40-42]. One pair of ILP7 expressing
neurons was described dorsally in A1. We applied antise-
rum to ILP7 to flies bearing sNPF-Gal4 and UAS-GFP
transgenes and found that indeed the sNPF expressing DP
neurons of A1 co-express ILP7-immunolabeling (Fig. 16F,
G). No other neurons coexpress the two markers in the
larval CNS.
Since it was shown that the ILP7-expressing DP neurons
have ascending axons that terminate on the dendrites of
the ILP producing median neurosecretory cells (MNCs) of
the larval brain [41] we wanted to analyze sNPF immu-
nolabeling in relation to these MNCs. We used a Dilp2-
Gal4 line to identify the ILP producing MNCs in the larva
and found that indeed sNPFp-immunolabeled axon ter-
minations localize close to the MNC dendrites in the pars
intercerebralis (Fig. 16H). Using the sNPF-Gal4 and
antiserum to ILP7 we also showed that the ILP7 express-
ing axon terminations in the brain coexpress sNPF (not
shown).
The main types of sNPF neurons co-expressing other
markers for chemical signaling components are summa-
rized in Table 1.
Mass spectrometry of Drosophila CNS reveals sNPF-1
There is some ambiguity with respect to which of the snpf-
derived peptides that are expressed in the CNS of Dro-
sophila. In several published accounts only sNPF-1 and
sNPF-14–11 (sequence identical to sNPF-212–19) have been
clearly revealed by mass spectrometry of larval CNS
extract or dissected neurohemal organs [43-45], whereas
in one paper [46] masses indicating also sNPF-2, 3 and 4
were detected in HPLC-purified whole body extracts. The
identity of the peptides behind these masses were, how-
ever, not confirmed with fragmentation analysis. Here we
used single microdissected portions of the larval and adult
brain for mass spectral analysis by direct peptide profiling.
These portions included the mushroom bodies, but nei-
ther the subesophageal ganglion, optic lobes (or the optic
lobe anlagen in larvae), nor the larval ring gland or adult
neurohemal organs. In the larval brain only sNPF-14–11
Expression of sNPF in the optic lobe Figure 10 (see previous page)
Expression of sNPF in the optic lobe. The left optic lobe is shown in frontal views (dorsal is up, the retina is to 
the left).A. Overview of optic lobe with anti-sNPF precursor (α-sNPFp) in magenta and Cha-Gal4-driven GFP (green) as a 
reference marker. Cell bodies expressing sNPFp are seen (mcb), mixed with Cha-expressing ones, distal to the medulla (Me), 
and at the base of the lobula (Lo), lcb. Immunolabeling in neuropils is seen in medulla and lobula, but not in the lamina (La). Also 
a neuropil basal to the lobula express sNPFp and Cha (term). B. Detail of sNPFp expression in medulla. Note two prominent 
layers of immunoreactivity in the basal medulla and scattered cell bodies distal to the neuropil (arrows). C. Expression of 
sNPF-Gal4 in the medulla (slightly oblique optical section). In addition to distal cell bodies (arrows) and neuropil processes 
basally, labeling is seen in R7 and R8 photoreceptor axons (likely to be ectopic Gal4 expression). D. Overview of sNPF-Gal4 
expression in lobula and lateral protocerebrum (LP). In the lobula a distal layer (arrow) strongly expresses GFP. One popula-
tion of columnar lobula neurons appear to terminate in a distinct neuropil (term) and have their cell bodies (cb) in a cluster at 
the base (part of the OL2 in Fig. 7A). E. Detail of columnar lobula neurons with cell bodies (cb) and terminations (term). These 
neurons have presumed dendrites distally in the lobula (arrow). Compare to immunolabeling in 10F and 10H1. F. Immunolabe-
ling with α-sNPFp reveals a pattern similar to the sNPF-Gal4 in D.G1 and G2. Some of the sNPFp-IR cell bodies (arrows) of 
the lobula cluster coexpress Cha-Gal4 (G2). Term, neuropil with terminations of sNPFp expressing neurons. H1 – H3. Other 
sNPFp-IR cell bodies (cb) of the lobula cluster do not coexpress Cha-Gal4.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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Larval sNPFp immunoreactive neurons do not coexpress DIMM Figure 11
Larval sNPFp immunoreactive neurons do not coexpress DIMM. Double labeling of larval CNS with antiserum 
to sNPFp (magenta) and dimm-Gal4-driven GFP (c929-Gal4), voltex projections.A. Brain, subesophageal ganglion 
(SEG) and thoracic ganglia (ThG) with dimm-expressing neurons distinct from sNPFp-expressing ones. In the DLN cluster 
(arrows) in the brain corazonin-immunoreactive neurons (see Fig. 6C) can be found. These sNPF-corazonin expressing neu-
rons could possibly coexpress dimm [15] (but GFP may be too weak here to be seen). MNC, median neurosecretory cells; MB, 
mushroom body lobes; Ca, calyx. B. Higher magnification of right brain hemisphere of another larva with the sNPFp-expressing 
DLN cluster of cell bodies and dimm-expressing median neurosecretory cells (MNC). No dimm-expression is seen in any of 
these neurons. C – D. Double labeling with anti-sNPFp and c929-Gal4 in larval ventral nerve cord shown in maximum projec-
tions and voltex reconstruction. No colocalization of markers is seen. C. Ventral view of the segments A3 – A9. D. Dorsal 
view of the segments A1 – A2. E. Cross section (rear view) of the segments A1 – A2.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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Distribution of sNPF in relation to putative cholinergic neurons in the larval CNS Figure 12
Distribution of sNPF in relation to putative cholinergic neurons in the larval CNS. Antiserum to sNPFp (magenta) 
and Cha-Gal4-driven GFP (green) were used as markers. Single confocal sections are shown (anterior is upwards). A1 – 3. In 
the brain (protocerebrum) there are a few cell bodies in a dorso-lateral cluster displaying colocalized markers: one (arrowed in 
A2) is seen in boxed area of A3. This is also shown in enlarged view in A2' and A3'. B1 – 2. More dorsally in the brain a few 
other cell bodies in the protocerebrum display colocalized markers (arrows). C1 – 3. In the ventral nerve cord (abdominal 
ganglia) colocalized markers were seen in a small number of cell bodies (arrows). The boxed area (shown in higher magnifica-
tion in C2' and C3') contains a pair of dorsal neurons (DP) in A1 that colocalize Cha and sNPFp. A few more posterior abdom-
inal neurons with colocalized markers were found in adjacent sections.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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and sNPF-212–19 were detected (Additional File 3A). In the
adult brain portion we detected a major peak with the
mass corresponding to sNPF-14–11 and sNPF-212–19, but
only a very small one corresponding to sNPF-1 (Addi-
tional File 3B, C). Fragmentation analysis confirmed the
major mass peak as sNPF-14–11 (Additional File 3D). No
trace of full length sNPF-2, sNPF-3 or sNPF-4 was detected
in brains of either developmental stage. In congruence
with the present mass spectrometric data only sNPF-14–11/
sNPF-212–19 has so far been isolated biochemically and
sequenced from Drosophila [21]. In the larval ring gland a
more substantial peak representing sNPF-1 was detected,
but the sNPF-14–11/sNPF-212–19 signal was far stronger
[44]. Thus, it appears that except for sNPF-1, the originally
predicted peptides of the sNPF precursor are not liberated
at detectable levels; only the octapeptide SPSLRLRFamide
can be detected at high levels in the CNS.
Discussion
A diversity of neuron types express sNPF
We have investigated the widespread neuronal expression
of a Drosophila  neuropeptide gene snpf  and its peptide
products, sNPFs, in the larval and adult nervous system of
the fruitfly. This mapping was made by in situ hybridiza-
tion, a snpf-Gal4 line and immunocytochemistry with
antiserum specific for the snpf-derived precursor protein.
A large population of diverse neurons types was revealed
with the different sNPF/snpf markers: a few neurosecretory
cells, numerous interneurons of many kinds as well as
olfactory receptor neurons (ORNs) of the antennae. This
wide expression of sNPFs in diverse neuron types, many
of which may colocalize different neurotransmitters, sug-
gests a diversity of functions beyond that of any insect
neuropeptide studied so far. Especially the finding of
numerous small neurons such as Kenyon cells of the
mushroom bodies and olfactory receptor neurons
(ORNs) of the antennae and small neurons of the optic
lobe suggest that sNPFs play important roles in local
cotransmission and/or neuromodulation.
Since the intensity of immunolabeling with the sNPFp
antiserum was variable, especially for the smaller neuro-
nal cell bodies, it was hard to provide definite numbers of
smaller sNPF expressing neurons, in spite of analyzing
many specimens. Possibly part of this variability in immu-
nolabeling reflects bona fide fluctuations in sNPF levels
related to activity levels of neurons. Another drawback
with the immunolabeling was that it was mostly punctate
within neuronal processes and thus did not allow resolu-
tion of neuronal morphology beyond location of cell
bodies, major tracts and axon terminations. Therefore, the
majority of the sNPF expressing neuron types remain
anonymous cell bodies that cannot be connected to their
release sites. Apart from ORNs, a prominent exception to
the anonymity is seen for sNPF expression in the numer-
ous Kenyon cells that send sNPF-IR processes into the α,
β and γ lobes, but not the α' and β' lobes and αcβc portions
of these lobes [21]. Two other sets of neurons that could
be revealed in detail are the unique pair of DP neurons in
the first abdominal neuromere (A1) in larvae that co-
express ILP7 and the lateral protocerebral cells (LNCs)
coexpressing corazonin.
One aim here was to obtain data that could reveal func-
tional roles of sNPF expressing neurons. Does sNPF(s)
have distinct functions or is the function dependent on
the context of the neurons releasing the peptide(s). Gen-
erally neuropeptides are diverse and multifunctional sig-
nal substances [3,14,47-50]. In insects more than 30
genes encode precursors of neuropeptides that are known
to regulate many aspects of development, growth, repro-
duction, metabolism, homeostasis and behavior
[3,14,49-54]. Most of these regulatory roles are played by
neuropeptides released as hormones into the circulation
Distribution of sNPF in relation to putative cholinergic neurons in the adult brain Figure 13 (see previous page)
Distribution of sNPF in relation to putative cholinergic neurons in the adult brain. Brain is shown in frontal sec-
tions (dorsal is up). Antiserum to sNPFp (magenta) and Cha-Gal4-driven GFP (Green) revealed some neurons where markers 
are colocalized (note that the P{Cha-GAL4.W}19B is a fusion with cytoplasmic GFP). A1 – 3. Distribution of sNPF in axon ter-
minations of olfactory receptor neurons (ORNs) in a subset of antennal glomeruli (AG). The Cha expression is seen in both 
ORNs and projection neurons of the antennal lobe. B1 – 3. sNPF immunolabeling in cell bodies of a subset of Cha expressing 
ORNs in the antennae. The boxed area in B1 is shown magnified in B1' and B3'. The arrows in B1' and B3' indicate one of the 
ORNs expressing both markers C1 – 3. Cha and sNPF is also colocalized in interneurons in the deutocerebrum and 
subesophageal ganglion (arrows and boxed areas). Note that the GFP is mainly nuclear here. These images are slightly tilted; 
dorsal (d) is in direction of arrow. The boxed areas are shown enlarged in D and D'. E and F. Colocalization of Cha-expres-
sion and sNPF immunolabeling in a set of small cells laterally in the subesophageal ganglion (S3 neurons in Fig. 7A). G1 – 2. In 
the central body (fan-shaped body shown here) there is no neuronal colocalization of Cha and sNPF markers. The sNPFp 
antiserum labels neuronal processes in two layers (UD and LD) of the fan-shaped body, whereas Cha-expression is seen other 
processes in the UD and in a layer between this and the LD. H. There is no sNPFp-immunolabeling in the ellipsoid body (EB) 
of the central complex, whereas Cha expression is seen. VAL, ventral accessory lobe; BL, beta-lobe of mushroom body; AL, 
antennal lobe. The magnification of H is the same as in A.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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and some may act after episodic bulk release within the
CNS [15,55]. In addition, neuropeptides in interneurons
are likely to act as local cotransmitters or neuromodula-
tors in central neural circuits [16,48]. Peptidergic neurons
thus are of several different major types [16,15]: (1) large
neurosecretory cells with peripheral release sites that pro-
duce hormonal peptides, (2) a variety of circuit interneu-
rons, some of which are relatively small, produce
peptidergic cotransmitters (or local neuromodulators),
(3) a separate type of peptidergic interneurons of interme-
diate to large size are likely to be responsible for episodic
bulk transmission within the CNS and (4) subsets of
motoneurons are known to express the peptide proctolin
as cotransmitters [1,17,18]. To these types of peptide
expressing neuron types we can now add sNPF expressing
chemosensory neurons (ORNs) of the Drosophila anten-
nae and maxillary palps.
A recent paper [15] addressed the role of the transcription
factor DIMM in determining functional phenotypes of
peptidergic neurons. Expression of DIMM was seen only
in a portion of the known peptidergic neurons of Dro-
sophila, namely a set referred to as Large cells that Episod-
ically release Amidated Peptides (LEAP cells) [15]. These
LEAP neurons express both DIMM and PHM, an enzyme
required for alpha-amidation of neuropeptides [32], and
have large cell bodies and/or extensive arborizations and
axonal processes. Many peptide-expressing neurons were
found not to co-express DIMM (non-LEAP cells) [15] and
we indicate that the sNPF producing neurons in the larva
are of this kind. Using the c929-GAL4 as a marker for
dimm expression [24] and antiserum to the sNPF precur-
sor we found no neurons displaying coexpression in the
larval CNS. We hade expected a set of 3 pairs of LNCs dis-
playing sNPF and corazonin immunoreactivity to co-
express DIMM, but this was not the case. In the paper by
Park et al. [15] a set of five pairs of neurons were shown
to co-express DIMM and sNPF (antiserum to sNPF-2) in
the larval brain. Four of these have cell bodies medially
and colocalize dromyosuppressin (DMS) an FLRFamide-
like peptide and another set of six are located among the
LNCs and coexpress the neuropeptide corazonin. Since
these authors used an antiserum to the full peptide sNPF-
2 from Lee et al. [20] it is likely that the DMS expressing
neurons cross react with the sNPF-2 antiserum (due to the
shared RFamide). The corazonin-containing LNCs on the
other hand may indeed colocalize sNPF and DIMM. It
could be that we missed this colocalization in our preps
while the c929-driven GFP was too weak in the cells of
interest. As mentioned, we did reveal sNPFp and cora-
zonin colocalization in three pairs of LNCs in the position
described for the DIMM coexpressing ones [15] and if
these neurons are true neurosecretory cells they would
qualify as LEAP cells (however, see discussion below on
relation to AKH cells).
The finding of sNPF exclusively (maybe with exception
above) in small neurons that do not express DIMM sug-
gest that the sNPF expressing neurons might be signaling
locally and primarily in capacity of cotransmitter or local
neuromodulator. Another neuropeptide gene, dtk and its
DTK products, are also expressed mainly in small
interneurons [12,56] and Park et al. [15] found that in the
larva only one pair of dtk expressing neurons co-expressed
DIMM. This pair of neurons also expresses allatostatin B
(myoinhibitory peptide; MIP) and have extensive axonal
projections all along the ventral nerve cord. Thus it is
likely that both sNPF and DTKs are primarily cotransmit-
ters and/or local neuromodulators.
Colocalization of sNPF and other neurotransmitters
To seek support for a role of sNPFs in cotransmission we
screened for colocalized neurotransmitters in the large
population of sNPF immunoreactive neurons. In the
mammalian nervous system neuropeptides colocalize
extensively with classical neurotransmitters in interneu-
rons [47,48,57], but in insects systematic screens of such
colocalizations have not been performed (see [16]). Here,
for simplicity, we used Gal4 expression for marking possi-
ble neurotransmitter phenotypes. This choice was partly
Double labeling with antiserum to sNPFp and Gad1-Gal4-driven GFP Figure 14 (see previous page)
Double labeling with antiserum to sNPFp and Gad1-Gal4-driven GFP. Single confocal sections (horizontal views; 
anterior to top) are shown. A – C. No colocalization of the markers were seen in neurons of the larval ventral nerve cord (A 
dorsal aspect, B ventral aspect). The dorsal DP neurons in first abdominal ganglion (arrow in A) did not colocalize markers, 
although similar neurons expressing Gad1-Gal4 were seen in adjacent neuromeres. In C1-2 details of A1 are shown. D1 – 2. 
The sNPF-IR processes in neuropil overlap Gad1-Gal4 expressing branches in lateral neuropil of abdominal ganglia. Also the 
posterior neuropil (terminal plexus) in A8/9 (arrow) expresses both markers but, without colocalization (see also D2'). E. In 
the larval brain no colocalized markers were detected in neuronal cell bodies. The colocalization of Gad1-Gal4 and sNPF in the 
mushroom body lobes (aL) may be irrelevant here, since the Gad1-Gal4 does not support a GABAergic phenotype (see [85]). 
Most Gad1 expressing cell bodies are in the subesophageal ganglion (SEG) in this optical section. F1 – 2. In the adult brain 
colocalized markers (asterisks) can be seen in a group of dorsal median neurons in the protocerebrum (in the DMN cluster in 
Fig. 7A). G. In the dorso-lateral protocerebrum at the base of the Kenyon cell cluster (KC) some neurons (arrows) colocalize 
sNPF and Gad1-Gal4 (in the DLN2 cluster in Fig. 7A).BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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forced by the fact the available antisera to small molecule
neurotransmitters or their biosynthetic enzymes require
fixation protocols incompatible with sNPF detection, or
do not label neuronal cell bodies and thus precludes def-
inite localization to the same neuron. Immunolabeling
with sNPFp was made on Gal4-lines likely to reveal neu-
rons expressing GABA, glutamate, acetylcholine,
dopamine and octopamine/tyrosine. In this screen we did
detect some patterns of colocalization between sNPF and
GABA, glutamate and acetylcholine, but the majority on
the sNPFp-IR interneurons did not colocalize the markers
tested so far. The main findings on colocalized markers
are shown in Table 1.
The antennal ORNs are likely to be cholinergic[58] and
can thus be displayed by a Cha-Gal4 [33,34]. We found
that all sNPF expressing ORNs in the antennae indeed
coexpressed  Cha-Gal4-driven GFP. The presence of an
identified neuropeptide in arthropod chemosensory neu-
rons is a novel finding, although antisera to FMRFamide-
like peptides have been reported to label sensory axons in
blowflies, locusts and lobsters [59-61]. Especially intrigu-
ing is the finding that only a subpopulation of the ORNs
in the antenna and their axon terminations in the glomer-
uli in the antennal lobe express sNPF. Thus, most, if not
all, ORNs are cholinergic, but only a subpopulation
employ a putative peptidergic cotransmitter. It will be of
interest to identify the complete set of glomeruli receiving
sNPF-IR axons of ORNs to determine for which odors
additional peptidergic signaling is utilized.
We detected a number of further Cha-Gal4 expressing
neurons that colocalized sNPF in the larval and adult
brain, but very few in the ventral nerve cord. Both in the
brain and the ganglia these were primarily small interneu-
rons that could not be individually identified, except for a
pair of dorsal median neurons (DP) in A1 of the ventral
nerve cord. When analyzing sNPF in relation to Cha
expression in neuronal processes in brain neuropils we
could not detect colocalization of markers in central body
neuropils, mushroom bodies, optic lobe (with one excep-
tion in the lobula; Fig. 10H), whereas in the antennal
lobes the ORN terminations coexpressed the two. Thus
cholinergic interneurons that express sNPF appear to
arborize primarily in non-glomerular neuropils.
Fewer sNPF expressing neurons displayed markers for
glutamate (vGluT-Gal4) and GABA (Gad1-Gal4). These
neurons were in both cases located in the brain and no
colocalization was detected in the larval ventral ganglia.
Again the neurons were not possible to identify as individ-
uals and we did not see any specific patterns of colocaliza-
tion in processes in major neuropils. We detected no
colocalization between sNPF and markers for dopamine
and octopamine/tyramine. However, we did not investi-
gate the possible colocalization of sNPF and the biogenic
amines serotonin and histamine, known to be expressed
in distinct sets of neurons in the larval and adult CNS of
Drosophila [62-65].
In summary, except for the ORNs of the antennae and
abdominal DP neurons, it is not clear what specific types
of interneurons that coexpress the sNPF and the markers
for small molecule neurotransmitters. By screening labe-
ling in different neuropil regions of the adult brain we
could exclude peptide/transmitter coexpression in the
neurons of the central body, antennal lobes (except
ORNs), optic lobe and intrinsic neurons (Kenyon cells) of
mushroom bodies. The Kenyon cells are likely to express
a small molecule transmitter in addition to sNPF. A screen
for such a transmitter was made in a previous paper [21]
but no marker employed so far provided a lead to the
Kenyon cell transmitter. Several putative small molecule
transmitters remain to be investigated in Drosophila and
other insects (e. g. nucleotides/nucleosides, glycine, and
aspartate). It cannot be excluded that the small propor-
tion of sNPF neurons where we could see colocalized
markers was caused by deficiencies in the Gal4 lines uti-
lized: the gene expressions may be incomplete and thus
Labeling with antiserum to sNPFp and OK371- or TH-Gal4-driven GFP in the larval CNS Figure 15 (see previous page)
Labeling with antiserum to sNPFp and OK371- or TH-Gal4-driven GFP in the larval CNS. These Gal4 lines display 
expression of vesicular glutamate transporter (vGluT) and tyrosin hydroxylase, respectively. A1 – A2. Some colocalization of 
vGluT and sNPF was seen in a cell body group in the dorso-lateral protocerebrum (DLN; see Fig. 1E). A magnified view is 
shown in inset (arrows indicate cell bodies with colocalized markers). The beta-lobe (βL) of mushroom body is surrounded by 
OK371-expressing processes. B. More dorsally in the brain another cell body co-expresses markers (arrow). Ca, calyx of 
mushroom body. C – E. In the ventral nerve cord (abdominal ganglia shown here; anterior downwards) vGluT and sNPF 
appear not to be colocalized. In C1 and C2 sNPF-IR processes are seen in a dense terminal plexus neuropil of A8/9 (arrow), 
that is not supplied by vGluT expressing fibers. In D and E it can be seen that sNPF-IR cell bodies are located in clusters with 
vGluT expressing ones (arrows). In the more dorsal focal plane in E it is apparent that varicose sNPF-IR fibers run through 
neuropils with dense supply of vGluT expressing processes. F. Tyrosin hydroxylase expression (TH-Gal4) is seen in a pair of 
cell bodies in each of the abdominal ganglia A1 – A7 (green). These cell bodies are clustered with sNPF-IR cell bodies (e. g. at 
arrow), but no colocalization is seen anywhere in the CNS.BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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not reveal the entire populations of neurons expressing
the neurotransmitters intended.
Relation between sNPF and other neuropeptides, including 
ILPs
Since we were mainly interested in the colocalization of
sNPF and small molecule transmitters we did not make an
extensive screen for colocalization with other neuropep-
tides.
One exciting finding was that the two unique DP neurons
of A1 of larvae co-express the relaxin-like ILP7, as well as
Cha. These neurons were described first as ILP7 producing
neurons with ascending axons terminating close to the
dendrites of the ILP producing MNCs in the larval brain
[41]. Here we showed that the ascending ILP7 immunore-
active processes indeed colocalize sNPF and are part of a
slightly more extensive supply of sNPF-IR processes
impinging on Dilp2-Gal4 expressing MNCs. It was shown
that sNPF overexpression causes increased production of
ILPs in these MNCs and that the MNCs express the sNPF
receptor [31]. Thus, it is possible that sNPF together with
ILP7 (and maybe acetylcholine) regulate production of
other ILPs. It should be noted that we also could show
that sNPF immunolabeled varicose axons (from the three
pairs of LNCs) terminate close to AKH-producing cells in
the corpora cardiaca of the ring gland. This might suggest
that these sNPF producing cells could have a role in regu-
lation of the AKH cells, but it cannot be excluded that
sNPF is released as a circulating hormone. The same LNCs
have additional axons terminating in the anterior aorta
suggesting a hormonal release site.
Apart from the above findings we revealed one pair of
neurons in the dorsal protocerebrum (in DLN1 group) co-
expressing sNPF and NPF (long NPF) and noted an exten-
sive superposition of neuronal processes containing he
two peptides in the dorsal protocerebrum. Another set of
about six sNPF-IR neurons in the dorso-median brain
(pars intercerebralis) co-express Mai-179-Gal4. These par-
ticular neurons with axons in the median bundle and pos-
sible terminations in tritocerebrum were not described
among the neurosecretory cells innervating the ring gland
in Drosophila [27], but similar neurons were seen with an
Relation between sNPF-expression and other neuropeptides in the CNS Figure 16 (see previous page)
Relation between sNPF-expression and other neuropeptides in the CNS. Labeling with antiserum to sNPFp and GFP 
driven by Gal4s displaying peptide expression (dNPF, Mai179 and Dilp2) or antiserum to insulin-like peptide 7 (ILP7). A1 – 3. 
In the adult brain colocalization of sNPF-immunolabeling and dNPF-Gal4 expression (long NPF) is seen only in one cell body 
per hemisphere (arrow). These cell bodies are located in the DLN1 cluster of the dorsal protocerebrum. B1 – 2. In the adult 
dorsal protocerebrum (SLP) there is a dense supply of neuronal processes expressing sNPF (magenta) and dNPF (green), but 
no colocalized markers are seen in these processes. These images are slightly tilted (the dorso-ventral axis is indicated by the 
d-v line). γ, gamma lobe of mushroom body. C1 – 2. The Mai179-Gal4 drives GFP in a specific set of neurons (PI) in the adult 
pars intercerebralis (arrow). In a subset of these we find sNPF colocalized. DLN1, dorsal lateral neurons. D1 – 3 Details of 
Mai179-Gal4 and sNPF expression in adult pars intercerebralis neurons. At least four of these neurons express both markers 
(e. g. at arrows). E. In the larval thoracic-abdominal ganglia the neuropeptide corazonin (CRZ) is expressed in neurons 
(magenta) distinct from the sNPF-Gal4 expressing ones (green). F. Insulin-like peptide 7 (ILP7) immunoreactivity is detected in 
the DP neurons in A1 that co-express sNPF-Gal4 (merged image stack). G1 – 3. Single sections showing the coexpression of 
ILP7 and sNPF in DP neurons. H1 – 3. Relation between sNPFp-immunolabled axon terminations (magenta) and dendrites 
(arrow) of Dilp2-Gal4 expressing neurons (green) in pars intercerebralis. Note that the sNPF-expressing terminations impinge 
on the dendrites. Some of the sNPF-IR processes seen here are likely to be derived from the DP neurons.
Table 1: Neuronal colocalization of sNPF with other neuroactive substances
Neuron type colocalized substance acronym location stage figure
LNCs1 corazonin LNCs (DLG) brain larva2 6C
ORNs acetylcholine (Cha) antenna adult 13A, B
interneurons Cha DLG DP, others brain v. gangl larva 12A – C
interneurons Cha S3, others brain3 adult 13C, F, 10G
interneurons neuropeptide F DLN1 brain adult4 14A
interneurons ILP-7 DP v. gangl larva2 14F, G
interneurons GABA (GAD1) DMN, others brain adult4 Add. M. 3
interneurons glutamate (vGluT) DLN, others brain larva2 Add. M. 4
1 Neurosecretory cells
2 Adult not analyzed
3 Also in lobula of optic lobe
4 No colocalization detected in larvaeBMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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antiserum to Ion transport peptide (ITP) [66]. Thus, it
might be that these PI neurons coexpress ITP and sNPF.
How many peptides are produced by the snpf gene?
Mass spectrometry identified SPSLRLRFa, which corre-
sponds to both sNPF-14–11 and sNPF-212–19, as the major
product of the predicted sNPF-1 to 4. A small peak repre-
senting full length sNPF-1 was also detected. Thus, it
appears that sNPF-2 is processed to sNPF-212–19, and
sNPF-3 and 4 are not liberated from the precursor (see
also [43-45]). An antiserum to sNPF-3 used in a previous
study [21] labeled the same neurons as the one to the
sNPF precursor used here. Possibly that antiserum recog-
nizes the sNPF-3 and 4 sequences (with RLRWamide)
within the precursor, or too little peptide is produced to
be detected by mass spectrometry. The snpf genes of the
mosquitoes Anopheles gambiae, Aedes aegypti, and Culex
pipiens also predict RLRWamides like sNPF-3 and 4, but
not the ones in the honey bee or the red flour beetle Tri-
bolium  [50,53,54]. We propose that the neurons we
depicted with the sNPFp antiserum and ribonucleotide
probe express at least one peptide derived from the snpf.
Functions of sNPF: diverse or not?
Judging from the abundance of sNPF distribution in
diverse sets of neurons in the larval and adult CNS one
would anticipate multiple functions of these peptides. An
earlier study has addressed the general distribution and
role of sNPFs and its receptor sNPFR1 in feeding and
growth in Drosophila [20,31]. These authors showed that
sNPF signaling appears to be involved in regulation of
food intake and growth, [20], and also in the regulation of
Drosophila ILP expression via the sNPF receptor [31]. The
experiments were conducted by rather widespread over-
expression and knock-down of sNPF products and did not
address sNPF action in specific circuits. Thus, it is not clear
at what level the sNPF regulation of ILP producing cells
occurs. However, the sNPFR1 is expressed on Dilp2-gal4
expressing MNCs in brain and sNPF immunoreactive
processes were detected close to these cells [31], as also
shown here. Whatever the exact circuitry utilizing sNPF to
regulate ILP production, the effect of sNPF on growth via
ERK (extracellular signal-related kinases) signaling is
likely to be only a part of a spectrum of sNPF functions in
Drosophila. This function may be limited to a small subset
of the sNPF-expressing neurons.
Peptides likely to be orthologs of Drosophila sNPF have
been identified in other insects. In fact the first identifica-
tion of an sNPF (or Aedes head peptides) was in the mos-
quito  Aedes aegypti [67,68] and subsequently related
peptides have been identified in several other insect spe-
cies [50,53,69-71,54,72]. Some actions of sNPF have been
analyzed by peptide administration: sNPFs are myostim-
ulatory on various visceral muscles [68,71] induce host
seeking behavior in female mosquitoes [73], they may be
important for diapause in a beetle [74] and in locusts they
stimulate ovarian growth and induce increases in vitello-
genin levels in the circulation [71,75]. This spectrum of
actions, except the host seeking behavior, may represent
hormonal functions of sNPF. Thus, probably a host of
functions based on local actions of sNPF in circuits of the
CNS remain to be demonstrated.
Only a single Drosophila  sNPF receptor (NPFR76F;
CG7395; sNPFR1) has been identified [76-78]. This recep-
tor may couple to different signaling pathways, as already
suggested from in vitro experiments [31,76-78]. It has
been postulated that the sNPFR1 is related to the mamma-
lian neuropeptide Y type of receptors [76,77] and the
receptor for Drosophila  long NPF [51,79]. Long NPF is
encoded on a separate gene (npf), identified in Drosophila
and other insects [51,52,80]. This peptide is 36 amino
acids in length with an ARVRFamide C-terminus and
resembles neuropeptide Y of mammals. In spite of the
unfortunate similarities in names of the two peptide genes
and peptides, they are part of two functionally distinct sig-
naling systems [20,21,31,39].
Conclusion
The diverse distribution of sNPF in Drosophila suggests the
following functions: A role in olfaction at the level of the
first synapse between ORNs and second order neurons in
the antennal lobe, a role in olfactory processing (or olfac-
tory learning, or any of the other MB roles) at the level of
the mushroom bodies, neuromodulation in central body
circuits possibly involved in locomotor control, roles in
regulation of hormonal systems (ILPs and AKH producing
cells) or even as circulating neurohormones and finally
sNPF seem to have modulatory/cotransmitter functions in
numerous circuits in the brain and ventral nerve cord.
Colocalized putative neurotransmitters as well as neu-
ropeptides have been indicated in several subsets of sNPF
expressing neurons and a more complete screen is likely
to detect further examples. The colocalized substances
may be both excitatory (e. g. acetylcholine) and inhibitory
(GABA) or neuropeptides with various modulatory or
hormonal actions. Clearly more specific interference with
sNPF signaling in different neuron systems is required to
begin to understand the functional diversity of this pep-
tide.
Methods
Fly strains used
We used wild type (Oregon R) and white eyed (w1118)
fruitflies, Drosophila melanogaster for immunocytochemis-
try and in situ hybridization. A number of Gal4 strains
were used for driving GFP to identify specific sets of neu-
rons in relation to sNPF markers. These were: gad1-Gal4
(Glutamic acid decarboxylase-1 promoter-Gal4 [81]; fromBMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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G. Miesenböck, New Haven, CT), Cha-Gal4 (w*; P{Cha-
GAL4.7.4}19B P{UAS-GFP.S65T}T2; choline acetyltrans-
ferase promotor-Gal4-GFP fusion, from Bloomington
Drosophila Stock Center at Indiana University, IN [33]); th-
Gal4 (tyrosine-hydroxylase promoter-Gal4; [38]; from S.
Birmann, Marseille, France), tdc-Gal4 (tyrosine decarbox-
ylase promoter Gal4; obtained from J. Dubnau, Cold
Spring Harbor, NY; [82]), OK371-Gal4 (vesicular gluta-
mate transporter-Gal4) (from H. Aberle, Tübingen, Ger-
many [36]; OK107-Gal4 (P{GawB}OK107 (expression in
mushroom body neurons); from Bloomington Stock
center; [83,84]), npf-Gal4 (Neuropeptide F-promoter-
Gal4; from P. Shen, Athens, GA; [39]). A snpf-Gal4
(NP6301; order number 113901) was obtained from the
Drosophila Genetic Resource Center (DGRC), Kyoto Insti-
tute of Technology, Kyoto, Japan. The genotype of this
Gal4 is yw; P{GawB}NP6301/CyO, P{UAS-
lacZ.UW14}UW14. To our knowledge the expression of
this Gal4 has not been previously described. The enhancer
trap line Mai179-Gal4 [27] was obtained from G. Korge
(Berlin, Germany). This drives expression in a subset of
neurons in the brain including some neurosecretory cells.
The c929-Gal4 line was obtained from P. H. Taghert (St.
Louis, MO). This Gal4 reveals the Drosophila dimmed
(dimm) gene that encodes a bHLH protein, DIMM, known
to be required for the differentiation of peptidergic neu-
rons and endocrine cells [24]. Finally, UAS-cd8gfp flies
(from Bloomington Stock center) were used as targets to
express GFP.
In situ hybridization
The coding region of the snpf gene (0.85 kb) subcloned
into a pGEM-T easy vector (Promega, Madison, WI) was
kindly provided by Dr. K. Yu (Korea Research Institute of
Bioscience and Biotechnology, Daejeon, Korea;[20]). This
was amplified with polymerase chain reaction (PCR) and
the PCR product was cut with either APA1 (for antisense
strand) or Pst1 (for sense strand) and purified. An anti-
sense digoxigenin (Dig)-labeled snp probe was generated
with SP6 RNA polymerase and Dignucleotide (NTP/Dig-
UTP) mixture (Roche Diagnostics, Indianapolis, IN). As a
control we generated an snpf  sense probe with T7
polymerase. In situ hybridization on whole mount larval
CNS and adult brains (at least 10 specimens of each stage)
with the Dig-labeled snpf riboprobes (100 ng/l) was per-
formed according to Johard et al. [21]. In brief, tissues
were fixed in 4% paraformaldehyde (PFA) in 0.1 M
sodium phosphate buffer (PB) and 0.1% Tween 20 (PBT)
for 30 minutes at room temperature, washed in PBT and
incubated for 10 minutes in 20 g/ml proteinase K (Sigma,
St. Louis, MO) in PBT, at 37°C. A postfixation was made
for 20 minutes in 4% PFA. Prehybridization was per-
formed for 1 hour at 55°C in hybridization buffer consist-
ing of 50% formamide, 5× SSC, 140 mM NaCl, 10 mM
KPO4, 0.1 mg/ml glycogen, 100 g/ml heat-denatured her-
ring sperm DNA (Sigma), and 0.1% Tween 20. Hybridiza-
tion was carried out for 48 hours at 55°C. After thorough
washes anti-Dig immunocytochemistry was performed on
the tissues, starting by blocking in 4% normal goat serum
(NGS) or 1% milk powder in PBT. Alkaline phosphatase
(AP) tagged anti-Dig-antiserum (1:1,000) was added for 2
hours, and after washes AP histochemistry was performed
in nitroblue tetrazolium/5-bromo-4-chloro-3-indolyl
phosphate (NBT/BCIP) solution (Roche Diagnostics,
Mannheim, Germany) for about 1 hour. After washes, tis-
sues were mounted under coverslips in glycerol/PB
(80%).
Antisera used
We initially used antisera raised to three peptides pre-
dicted from the snpf precursor [21]: (1) SPSLRLRFamide,
expected to recognize the sNPF-1 and sNPF-2, (2) PQRL-
RWamide, expected to recognize sNPF-3 and sNPF-4, and
(3) DPSLPQMRRTAYDDLLEREL, which is part of the snpf
precursor (sNPFp) and not likely to be a bioactive peptide
[21]. These antisera were kindly provided by Dr. J. A.
Veenstra (Bordeaux, France). The peptides were coupled
with 1,5 difluoro-2,4-dinitrobenzene to bovine serum
albumin for immunization in rabbits, and antisera were
raised in two New Zealand white rabbits for each antigen.
The three peptide sequences used for immunization were
also employed for preabsorption of antisera in immuno-
cytochemical specificity tests. The working dilution for
primary antisera in the experiments were as follows: anti-
SPSLRLRFamide at 1:1000, anti-PQRLRWamide at 1:1000
and anti-DPSLPQMRRTAYDDLLEREL at 1:4000.
Throughout the present paper we only used the sNPFp
antiserum for imaging.
A rabbit antiserum to the neuropeptide corazonin (kind
gift from Dr. J. A. Veenstra, Bordeaux, France) was used at
1:2000 (see [28]). A rabbit antiserum to the B-chain of
Drosophila insulin-like peptide 7 (ILP-7), used at 1:5000,
was a kind gift from Dr. I. Miguel-Aliaga (London, UK)
[41]. Mouse monoclonal antibodies to fasciclin-2 (anti-
Fas2; mAb 1D4) were obtained from the Developmental
Studies Hybridoma Bank (University of Iowa, IA) and
used at 1:75). These were used for double labeling with
sNPF antisera to provide a correlation to known axonal
tracts (see [7,25]). A mouse monoclonal antibody to GFP
(mAb 3E6; code #A-11120; Molecular Probes, Leiden,
Netherlands) was used at 1:1000 for amplifying the GFP
signal in some specimens.
Immunocytochemistry
For most purposes opened head regions of feeding third-
instar larvae of opened adult heads were fixed for two
hours in 4% paraformaldehyde (PFA) in 0.1 M sodium
phosphate buffer (PB; pH 7.4) on ice. Following rinsing in
PB, the central nervous system was dissected out and pre-BMC Neuroscience 2008, 9:90 http://www.biomedcentral.com/1471-2202/9/90
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incubated over night in incubation buffer consisting of
0.01 M phosphate-buffered saline, pH 7.4, with 0.25%
BSA and 0.25% Triton-X and 3% Normal Goat Serum.
Incubation with primary antisera were performed for 48 h
in dark at 4°C with gentle agitation followed by thorough
rinses in PBS with Triton-X at room temperature. The pri-
mary antibodies were detected with Cy3-conjugated goat
anti-rabbit antiserum (Jackson ImmunoResearch, West
Grove, PA) or Cy2- or Cy3-conjugated goat anti-mouse
antiserum (Jackson ImmunoResearch) all used at 1:1500
or 1:1000. Some specimens were processed for peroxidase
based detection using the biotin-streptavidine method
(with peroxidase histochemistry) employing a commer-
cial ABC kit (Vectastain) from Vector Laboratories (Burl-
ingame, CA) according to the instructions supplied by the
manufacturers.
For cryostat sections fixed heads were put in 20% sucrose
over night and subsequently frozen at -23°C and cut at 20
μm on a cryostat (Leitz, Wetzlar, Germany). Sectioned tis-
sues were subjected to the same immunocytochemical
procedure as above. Preincubations of antisera with their
respective antigens and other specificity tests for immuno-
cytochemistry were described previously [21].
Image analysis
Specimens were imaged with a Zeiss LSM 510 (Zeiss, Jena,
Germany) or a Leica TCS SP2 (Leica Microsystems, Wet-
zlar, Germany) confocal laser scanning microscope. Con-
focal images were obtained at an optical section thickness
of 0.4 – 0.5 μm and were processed with Zeiss LSM or
Leica Confocal Software and edited for contrast and
brightness in Adobe Photoshop CS3 Extended.
To obtain 3D reconstructions, confocal stacks were sub-
jected to either texture-based volume rendering using the
voltex tool, or to threshold-based surface generation with
the LabelVoxel and Threshold Segmentation tool of
AMIRA 4.1 software (Mercury Computer Systems GmbH,
Berlin, Germany).
Wholemounted specimens treated for in situ hybridiza-
tion or peroxidase-based immunocytochemistry were
used for tracings of neuronal cell bodies with a drawing
tube attached to a compound microscope. Images of in
situ hybdridization were generated on a Zeiss Axioplan 2
microscope equipped with a Zeiss Axiocam HRM CCD
camera.
Mass spectrometry
The brain of either larvae or adults was dissected free from
all surrounding tissue in standard Drosophila saline. Optic
anlagen or lobes and the ring gland/aorta were removed
with fine scissors. The remaining brain was cut transver-
sally in the middle. The dorsal part, which roughly corre-
sponded to the protocerebrum, was then slightly trimmed
dorsally and laterally, and cut medially. The resulting tis-
sue fragments each contained a mushroom body, as
checked under a phase contrast microscope. The frag-
ments were transferred to a stainless steel MALDI target
and attached saline was aspirated off, and the preparation
was left to dry. Afterwards, nanoliter volumes of matrix
(saturated solution of recrystallized α-cyano-4-hydroxy-
cinnamic acid (CHCA, Sigma-Aldrich) in 30% MeOH/
30% EtOH) were added to the samples using a manual
oocyte injector (Drummond Digital).
MALDI-TOF mass spectra were acquired in positive ion
mode on a Applied Biosystems 4800 plus mass spectrom-
eter (Applied Biosystems, Darmstadt, Germany). Samples
were analyzed in reflectron mode after calibration with
synthetic peptides. To suppress matrix signals, the low
mass gate was set to 800 Da. Laser power was adjusted to
provide optimal signal-to-noise ratios. Data were ana-
lyzed using Data Explorer 4.3 software (Applied Biosys-
tems), with a mass tolerance of 0.1 Da.
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